Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Annals of Nuclear Medicine|September 17, 2005
Scintigraphic evaluation of regression of abnormal Q waves in myocardial infarctionTetsuo Konno, Masami Shimizu, Hidekazu Ino, et al.
European Heart Journal|February 20, 2004
Diagnostic value of abnormal Q waves for identification of preclinical carriers of hypertrophic cardiomyopathy based on a molecular genetic diagnosisTetsuo Konno, Masami Shimizu, Hidekazu Ino, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|April 6, 2026
Intentional internal high-dose policy in VMAT for stage III NSCLC with consolidation durvalumab - a retrospective studyKae Okuma, Tairo Kashihara, Yuko Nakayama, et al.
Clinical Science (London, England : 1979)|October 27, 2004
Compound heterozygosity for mutations Asp611-->Tyr in KCNQ1 and Asp609-->Gly in KCNH2 associated with severe long QT syndromeMasato Yamaguchi, Masami Shimizu, Hidekazu Ino, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 31, 2015
Comparison of genitourinary and gastrointestinal toxicity among four radiotherapy modalities for prostate cancer: Conventional radiotherapy, intensity-modulated radiotherapy, and permanent iodine-125 implantation with or without external beam radiotherapyShinya Sutani, Toshio Ohashi, Masanori Sakayori, et al.
Journal of Contemporary Brachytherapy|December 10, 2020
Transvaginal artificial ascites infusion as a spacer in gynecological brachytherapy: a novel techniqueMasataka Karube, Naoya Murakami, Hiroyuki Okamoto, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2011
Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patientsYutaka Shiraishi, Atsunori Yorozu, Toshio Ohashi, et al.
Clinical Science (London, England : 1979)|September 27, 2005
A novel mutation in the cardiac myosin-binding protein C gene is responsible for hypertrophic cardiomyopathy with severe ventricular hypertrophy and sudden deathTetsuo Konno, Masami Shimizu, Hidekazu Ino, et al.
American Heart Journal|February 9, 2002
Chronologic electrocardiographic changes in patients with hypertrophic cardiomyopathy associated with cardiac troponin 1 mutationMasami Shimizu, Hidekazu Ino, Masato Yamaguchi, et al.
Journal of Cardiology Cases|October 4, 2018
Limited effects of long-term enzyme replacement therapy on the cardiac conduction system in Fabry diseaseTomoya Kaneda, Masahiro Takeda, Tetsuro Suematsu, et al.
Pageof 7